Keyboard shortcuts

Press ← or → to navigate between chapters

Press S or / to search in the book

Press ? to show this help

Press Esc to hide this help

Longevity research takeaways

(authored by agents unless marked 🧑)

Population/biology evidence synthesis, top-tier venues only. Not personal medical advice. Written 2026-11-10 from the agent’s knowledge of the literature; PDFs and DOIs in /hdd1/sichanghe/paper_collection/longevity/index.md.

Bottom line

  • Lifespan in animals is clearly modifiable: calorie restriction (CR), rapamycin, and removing senescent cells extend mouse lifespan in well-controlled studies.
  • No intervention is yet proven to extend human lifespan or healthspan.
  • David Sinclair’s program (sirtuins → NAD+ → epigenetic information loss → reprogramming) produced high-profile papers, but each early pillar was weakened by later independent work; the newest pillar (reprogramming) is promising but early.

Established (replicated, independent labs)

  • Aging has a set of interacting mechanisms (“hallmarks”): genomic instability, telomere loss, epigenetic change, proteostasis loss, nutrient-sensing dysregulation, mitochondrial dysfunction, senescence, stem-cell exhaustion, altered communication, plus inflammation, dysbiosis, impaired autophagy (LĂłpez-OtĂ­n 2013 and 2023, Cell).
  • Rapamycin (mTOR inhibitor) extends mouse lifespan even when started late; replicated across sites by the NIA Interventions Testing Program (ITP) (Harrison 2009, Nature).
  • Clearing p16Ink4a-positive senescent cells extends healthy lifespan in mice (Baker 2016, Nature).
  • CR extends healthspan/survival in rhesus monkeys once the two conflicting NIA/Wisconsin studies are reconciled by diet and start age (Mattison 2017, Nat Commun). In humans, 2-year moderate CR improves cardiometabolic risk factors, not proven outcomes (CALERIE 2, Kraus 2019, Lancet Diabetes Endocrinol).
  • DNA-methylation “clocks” predict age and mortality risk; DunedinPACE measures rate of aging (Belsky 2022, eLife). Inference: clocks are biomarkers, not proof that changing a clock changes lifespan.

Contested

  • Sirtuins / resveratrol
    • claim: resveratrol activates SIRT1 and extends yeast lifespan (Howitz 2003, Nature) and mice on high-calorie diet (Baur 2006, Nature)
    • critique: activation was an artifact of fluorescent test substrates (Pacholec 2010, J Biol Chem); Sir2 overexpression lifespan effects in worms and flies vanished after controlling genetic background (Burnett 2011, Nature)
    • rebuttal: SIRT1 allosteric activation is real for some substrates (Hubbard 2013, Science)
    • decisive: resveratrol did not extend lifespan of normal-diet mice in the ITP (Strong 2013, J Gerontol A)
    • read: no reliable lifespan benefit in healthy mammals
  • NAD+ precursors (NMN, NR)
    • claim: NAD+ falls with age; restoring it reverses mitochondrial/muscle/vascular decline in mice (Gomes 2013, Cell; Mills 2016, Cell Metab)
    • human: NMN raised muscle insulin sensitivity in prediabetic women, a modest single-endpoint effect (Yoshino 2021, Science)
    • against: NR did not extend lifespan in the ITP (Harrison 2021, Aging Cell)
    • read: raises NAD+ reliably; healthspan/lifespan benefit in humans unshown
    • regulatory side-story: FDA in 2022 ruled NMN excluded from supplements because it was under drug investigation, then on 2025-09-29 said NMN is lawful in supplements because it was sold as one before the drug investigation (FDA response to Natural Products Association, reported by NutraIngredients); legal status says nothing about efficacy
  • Information theory of aging (Sinclair)
    • claim: loss of epigenetic information causes aging; inducing DNA breaks (ICE mice) accelerates aging, and OSK reprogramming reverses it (Yang 2023, Cell)
    • critique (inference/opinion from field): ICE damage may mimic damage rather than normal aging; the “cause” claim outruns the evidence
  • Partial reprogramming
    • cyclic OSKM expression improved hallmarks and lifespan in progeroid mice (Ocampo 2016, Cell)
    • OSK gene therapy restored vision in old and glaucomatous mice (Lu 2020, Nature)
    • risks: teratoma and loss of cell identity; effect on normal-mouse lifespan is small or unclear
    • read: most promising rejuvenation idea; years from human proof

Actionable (inference, for a healthy adult)

  • Proven levers remain boring: exercise, not smoking, blood pressure/ApoB/glucose control, sleep, avoiding obesity (see cholesterol note).
  • Do not expect supplements (resveratrol, NMN, NR) to extend life; top-tier evidence does not support it.
  • Rapamycin, metformin (TAME trial), and senolytics are research-stage for longevity in humans.
  • Treat epigenetic-clock “age reversal” claims as biomarker changes, not outcome evidence.

Last edited: